CDKN2A and breast cancer: The most common genetic alteration in BC tumors is a deletion in chromosome 9 that results in copy number loss of cyclin dependent kinase inhibitor 2A (CDKN2A) and Tuberous Sclerosis complex subunit 1 (TSC1).